Form 8-K BIOGEN INC. For: Oct 14
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 7/7/2026
- Rivian Automotive (RIVN) files for 75M share offering
- Rivian offers Q2 2026 revenue outlook, cash position grows
- Nokia OYJ (NOKIA:FH) (NOK) PT Raised to EUR14 at Kepler Cheuvreux
- Meta capex to surge in 2027, neocloud fears ’erroneous’ - SemiAnalysis
- Coursera plans layoffs after Udemy merger, estimates $8M-$11M in costs
Biogen expects $2 million charge in third quarter 2025
October 14, 2025 4:21 PM EDTBiogen Inc. (NASDAQ: BIIB) announced it expects approximately $2 million in acquired in-process research and development, upfront and milestone expenses on a pre-tax basis for the third quarter of 2025.
The biotechnology company said the estimated charge will impact both GAAP and non-GAAP net income... More
